OT PING METER
Report
- Report Number
- 2939301-2010-07379
- Event Type
- Malfunction
- Date Received
- August 30, 2010
- Report Date
- August 24, 2010
- Manufacturer
- LIFESCAN, INC.
- Product Code
- MDS
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- ID, US
- Reporter Occupation
- OTHER
Narratives
THE LAY USER/PATIENT'S PRODUCT(S) HAS BEEN RETURNED AND EVALUATED BY LIFESCAN PRODUCT ANALYSIS WITH THE FOLLOWING FINDINGS: THE METER INVOLVED IN THIS CASE FAILED TESTING. THE METER WAS FOUND TO HAVE CRACKED/BROKEN DISPLAY. IF ANY ADDITIONAL INFORMATION IS AVAILABLE, THE FDA WILL BE NOTIFIED IN A SECOND FOLLOW UP REPORT. AT THIS TIME, WE CONSIDER THIS MATTER CLOSED.
LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.
PRODISC-L IMPLANTED FOR DEGENERATIVE DISC DISEASE (B)(6) 2009. PT INVOLVED IN MVA (B)(6) 2009. X-RAY TAKEN (B)(6) 2009, STATUS POST MVA SHOWED PDL ALIGNMENT INTACT WITH NO ABNORMALITIES. POST-OP FILMS TAKEN FOR A ONE YEAR FOLLOW UP SHOWED POLYETHYLENE INLAY HAD DISLODGED. PT EXPERIENCED PAINFUL SYMPTOMS FROM LOWER BACK AND PAIN RADIATING IN LEFT LEG. RIGHT LEG WOULD 'GO TO SLEEP' WHEN LAYING FLAT ON BACK. PT REPORTED ORIGINAL PAIN SYMPTOMS IMPROVED FOR APPROX 6 MONTHS, THEN PAIN RETURNED. MRI TAKEN (B)(6) 2010 SHOWED CONSIDERABLE PARAMAGNETIC ARTIFACT. NO APPRECIABLE CHANGE IN APPEARANCE OF SPINE COMPARED TO PREOP STUDY DONE (B)(6) 2008. THIS IS THE 3RD OF 3 REPORTS SUBMITTED ON THIS EVENT.
THE LAY USER/PATIENT CONTACTED LIFESCAN ALLEGING THE METER HAS A DAMAGED DISPLAY. THE ISSUE WAS NOT RESOLVED WITH TROUBLESHOOTING. THERE WERE NO ALLEGATIONS OF HARM OR INJURY. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | OT PING METER | GLUCOSE MONITORING SYS/KIT | MDS | LIFESCAN, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 13 YR |